Mirati Therapeutics Inc (NASDAQ:MRTX)

24.40
Delayed Data
As of Mar 04
 +0.85 / +3.61%
Today’s Change
13.69
Today|||52-Week Range
24.48
+31.75%
Year-to-Date
No recent news for Mirati Therapeutics Inc.

Today’s Trading

Previous close23.55
Today’s open23.33
Day’s range-- - --
Volume31,275
Average volume (3 months)57,713
Market cap$379.7M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)-59.28%
Earnings growth (this year)+30.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book12.23

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+1.00+7.68%
IMDZImmune Design Corp+0.68+2.97%
SUPNSupernus Pharmaceuti...+0.33+3.61%
ACRXAcelRx Pharmaceutica...+0.18+2.02%
Data as of 03/04/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$0.00
Annual profit (last year)-$52.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
COO, Secretary, EVP &
Head-Investor Relations
Mark J. Gergen
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account